Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Almac, MGB Biopharma Collaborate on Manufacturing | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Almac, MGB Biopharma Collaborate on Manufacturing

Will work on DNA minor groove binder

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Almac’s Sciences Business Unit will manufacture the production of MGB Biopharma‘s lead gram positive antibacterial compound MGB-BP3. The compound is a DNA minor groove binder and is currently in preclinical development, with IND filing targeted for Q3 2012.

MGB Bio’s chief executive officer, Dr. Miroslav Ravic, commented, “We were very quickly impressed with the approach taken by Almac and they have already shown an intuitive understanding of what it takes to support a small company like ours. We look forward to a continued successful relationship.”

Rick Dyer, vice president Operations at Almac, remarked, “Almac has a wealth of expertise in early phase clinical development and we are delighted to undertake this phase of work for MGB Biopharma and hope this is the first of many successful projects between our companies.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics